The Zio Event Card The ZIO® Event Card is a prescription-only, single-use, disposable, looping ECG monitor that can be worn for up to 30 days. With the profile of three stacked credit cards and weighing less than 2 ounces, the ZIO Event Card is intended to be comfortable to wear …
Read More »Yearly Archives: 2014
Letter from the Editor, #756
When the first gastric bypass was done, the incision was about 6-9 inches long. Then came lap band surgery for weight loss. We have gone from 4 incisions to one small incision over the past five years. We are always looking for less-invasive ways to help our patients lose weight …
Read More »Editor’s Note, DCMS #215
A little over five years ago, a small company came to market with a low-dose rapid-acting dopamine receptor agonist with a claim that it could reset metabolism endpoints in the neuroendocrine system. Soon as prescribers heard the word “dopamine,” red flags went up and prescribing has gone nowhere. This week …
Read More »Aaron Vinik, MD, Q2: Why BG Levels May Be Less Important than Dopamine in CVD
Dr. Aaron Vinik continues his discussion of why the “glucophiles” and those promoting lower lipids may be missing a larger picture which involves dopamine levels in the brain. In this in-depth analysis, he talks about what we may have been missing all along and some of the past research studies …
Read More »Aaron Vinik, MD, PhD, FCP, MACP: How Does Glycemic Control Relate to CV Diseases?
In answering a question on the status of cycloset as a glucose lowering drug, Dr. Aaron Vinik delves into the deeper question of how glycemic control relates to effective cardiovascular therapy. He talks about the ACCORD trial and what we learned from that, and his answers may surprise you….
Read More »Diabetes Mellitus 101 for Cardiologists, Part 6
In this week’s Homerun Slides, Dr. Stanley Schwartz talks about the Annual Cycle of Metabolism that has helped keep humans alive for tens of thousands of year but is now working to our disadvantage instead resulting in Modern Insulin Resistant Man…. To download these slides in PowerPoint (.ppt) format, use this link: Diabetes …
Read More »Handbook of Diabetes, 4th Ed., Excerpt #18: Hypertension in Diabetes
Rudy Bilous, MD, FRCP Richard Donnelly, MD, PHD, FRCP, FRACP Diabetes and hypertension have been termed the ‘bad companions’ for cardiovascular disease risk. Diabetes alone increases this risk 2 – 4-fold; in the presence of hypertension, the risk for coronary heart disease is further trebled and for stroke, doubled. There is also …
Read More »Why Daily Movement Improves Your Brain Health (Part 3): The Remaining Reasons
by Dr. Sheri Colberg, Ph.D., FACSM As my final column on brain health, here are the final reasons why your brain needs for you to be active regularly. Beyond the brain-released hormone, leptin arising from fat cells impacts brain health, as do gut bacteria.
Read More »Verapamil Studied in Prevention, Development of Diabetes
Trial will study calcium channel blocker thought to decrease protein production and protect against development of type 1 and type 2 diabetes…
Read More »New Approach Targets Type 2’s Poorly Controlled With Metformin
Add-on of saxagliptin plus dapagliflozin shows greater improvements in glycemic control versus the use of single drug with metformin…. Because of the progressive nature of the disease, patients with type 2 diabetes regularly require various antidiabetic agents to achieve and maintain glycemic control. This study assessed the efficacy and safety …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.